Prof. Florent Malard- The First microbiota therapy approved by the US FDA By efrat|2022-12-06T11:42:16+00:00December 6th, 2022|All|Comments Off on Prof. Florent Malard- The First microbiota therapy approved by the US FDA Share This Story, Choose Your Platform! FacebookXRedditLinkedInWhatsAppTumblrPinterestVkEmail About the Author: efrat Related Posts September 20th 2024- Prof. Qian Jiang- A Predictive Model for Therapy Failure in CML Patients Receiving Tyrosine Kinase Inhibitor Therapy September 20th 2024- Prof. Qian Jiang- A Predictive Model for Therapy Failure in CML Patients Receiving Tyrosine Kinase Inhibitor Therapy September 13th 2024- Prof. Martin Ellis- Differential Effects of Itacitinib, Fedratinib, and Ruxolitinib in Mouse Models of Hemophagocytic Lymphohistiocytosis September 13th 2024- Prof. Martin Ellis- Differential Effects of Itacitinib, Fedratinib, and Ruxolitinib in Mouse Models of Hemophagocytic Lymphohistiocytosis September 2nd 2024- Prof. Mark Litzow- Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults September 2nd 2024- Prof. Mark Litzow- Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults August 26th 2024- Prof. Olaf Penack- How risky is a second allogeneic stem cell transplantation? August 26th 2024- Prof. Olaf Penack- How risky is a second allogeneic stem cell transplantation? July 22nd 2024- Dr. Kai Rejeski- A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy July 22nd 2024- Dr. Kai Rejeski- A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy
